Negev Capital logo

Negev Capital

North America, Midland, Cayman Islands, Grand Cayman

Description

Negev Capital primarily target psychedelic companies with interventions that are at early-mid stages of clinical development.

Investor Profile

Negev Capital has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Seed (38%)
  • Series B (25%)
  • Series A (25%)
  • Post Ipo Equity (13%)

Country Focus

  • United States (75%)
  • United Kingdom (13%)
  • Australia (13%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Alternative Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Negev Capital frequently co-invest with?

Ambria Capital
North America, NA - Puerto Rico, Puerto Rico, San Juan
Co-Investments: 2
Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 2
K2 & Associates
North America, Ontario, Canada, Toronto
Co-Investments: 2
JLS Fund
North America, New York, United States, New York
Co-Investments: 2
Day One Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Prime Movers Lab
North America, Wyoming, United States, Jackson
Co-Investments: 2
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Ayuh Ventures
North America, Delaware, United States, Dover
Co-Investments: 3
PS
North America, Illinois, United States, Highland Park
Co-Investments: 3
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 3

Which angels does Negev Capital often collaborate with?

AM
North America, California, United States, San Francisco
Shared Deals: 1
VH
North America, New York, United States, New York
Shared Deals: 1
GS
North America, Indiana, United States, Indianapolis
Shared Deals: 1
RH
Europe, Ile-de-France, France, Paris
Shared Deals: 1
JT
North America, Georgia, United States, Atlanta
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
MH
North America, California, United States, San Francisco
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Negev Capital?

Filament Health

Vancouver, British Columbia, Canada

Filament Health is a natural psychedelic extraction and drug discovery company

Health Care
Post Ipo EquityApr 3, 2025
Amount Raised: $631,758
Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BDec 15, 2022
Amount Raised: $39,000,000
Psylo

Sydney, New South Wales, Australia

Psylo is a drug development company that focuses on next-generation psychedelics.

Biotechnology
SeedOct 27, 2022
Amount Raised: $3,225,276
Reset Pharmaceuticals

New York, New York, United States

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

BiotechnologyHealth CareMedical
Series AFeb 16, 2022
Amount Raised: $11,100,000
Mindstate Design Labs

Pittsburgh, Pennsylvania, United States

Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.

BiotechnologyHealth CareTherapeutics
SeedFeb 10, 2022
Amount Raised: $11,500,000
Delix Therapeutics

Boston, Massachusetts, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

BiotechnologyHealth CareLife Science
Series ASep 27, 2021
Amount Raised: $70,000,000
MycroDose Therapeutics

San Diego, California, United States

Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems

Health CarePharmaceutical
SeedSep 21, 2021
Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Series BAug 15, 2021
Amount Raised: $80,404,797
WeSana Health

Homer Glen, Illinois, United States

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine.

Alternative MedicineHealth CareTherapeutics
Post Ipo EquityMar 31, 2021
Amount Raised: $12,813,472